Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Magahis PT, Westerveld D, Simons M, Hissong E, Carr-Locke DL, Sampath K, et al. EUS-guided liver biopsy using a novel hydrostatic stylet technique. VideoGIE. 2023;8(3):104-106.

Sloan SL, Brown F, Long M, Weigel C, Koirala S, Chung J-, et al. PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma. Blood. 2023;142(10):887-902.

Girardi NI, Cushing MM, Evered LA, Benedetto U, Schwann TA, Kurlansky P, et al. Incidence and Impact of a Single-Unit Red Blood Cell Transfusion: Analysis of The Society of Thoracic Surgeons Database 2010-2019. Ann Thorac Surg. 2023;115(4):1035-1041.

Medford AJ, Oshry L, Boyraz B, Kiedrowski L, Menshikova S, Butusova A, et al. TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. Ther Adv Med Oncol. 2023;15:17588359231152844.

Yang HS, Wang F, Greenblatt MB, Huang SX, Zhang Y. AI Chatbots in Clinical Laboratory Medicine: Foundations and Trends. Clin Chem. 2023;69(11):1238-1246.

Gould CV, Free RJ, Bhatnagar J, Soto RA, Royer TL, Maley WR, et al. Transmission of yellow fever vaccine virus through blood transfusion and organ transplantation in the USA in 2021: report of an investigation. Lancet Microbe. 2023;4(9):e711-e721.

Geng C, Zhang M-, Manyam GC, Vykoukal JV, Fahrmann JF, Peng S, et al. SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression. Clin Cancer Res. 2023;29(21):4464-4478.

Hwang JK, Magro CM, Lipner SR. Nail Unit Arteriovenous Hemangioma Presenting as Longitudinal Erythronychia. Skin Appendage Disord. 2023;9(4):300-305.

Galbraith K, Vasudevaraja V, Serrano J, Shen G, Tran I, Abdallat N, et al. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. Neurooncol Adv. 2023;5(1):vdad076.

Bandini C, Mereu E, Paradzik T, Labrador M, Maccagno M, Cumerlato M, et al. Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma. Exp Hematol Oncol. 2023;12(1):71.